HF
FTH

HRT Financial’s Faeth Therapeutics FTH Stock Holding History

HRT Financial’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
+58,001
New +$1.16M ﹤0.01% 1673
2025
Q1 		– Sell
-580
Closed -$5K – 3323
2024
Q4 		$5K Buy
+580
New +$5.82K ﹤0.01% 2324

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HRT Financial's FTH Position: Q1 2026 in Review

HRT Financial opened a new position in Faeth Therapeutics (FTH) in Q1 2026: 58,001 shares worth $1.83M. The stake represents ﹤0.01% of the portfolio and ranks #1673 among its holdings. This is a return to the name: HRT Financial previously reported a position in FTH as recently as Q4 2024.

HRT Financial first reported a position in FTH in Q4 2024 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • HRT Financial held 58,001 shares of Faeth Therapeutics worth $1.83M as of Q1 2026.
  • Faeth Therapeutics was a new HRT Financial position in Q1 2026.
  • Faeth Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1673 holding.
  • HRT Financial first reported a position in Faeth Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.